Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Apr 20;36(4):542-50.
doi: 10.1016/j.immuni.2012.03.014.

JAK and STAT signaling molecules in immunoregulation and immune-mediated disease

Affiliations
Review

JAK and STAT signaling molecules in immunoregulation and immune-mediated disease

John J O'Shea et al. Immunity. .

Abstract

The discovery of the Janus kinase (JAK)-signal transducer and activator of transcripton (STAT) signaling pathway, a landmark in cell biology, provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins. As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technology that permits genome-wide views. As we celebrate the 20(th) anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease. Not only have genome-wide association studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.

PubMed Disclaimer

Conflict of interest statement

Competing interests:

JO’S and National Institutes of Health (NIH) hold patents related to targeting JAKs as targets for immunomodulatory agents and have a Collaborative Research Agreement and Development Award with Pfizer.

Figures

Figure 1
Figure 1
Genetics links of cytokine signaling with human autoimmune disease. Although various animal models have implicated cytokines, their receptors, JAKs and STATs with autoimmune disease, genomewide association studies (GWAS) now show that these factors are truly relevant to human disease. This work shows that pathways that lead to STAT3 and STAT4 activation lie at the heart of many common autoimmune diseases Adapted from (Cho and Gregersen, 2011). AS – ankylosing spondylitis, IBD – inflammatory bowel disease; PBC –primary biliary cirrhosis, SLE – systemic lupus erythematosus.
Figure 2
Figure 2
Consequence of Jak inhibition on signaling by key immunoregulatory cytokines. A variety of JAKinibs have been developed with varying degrees of specificity for the different Jaks. The consequences of inhibiting each of the Jaks on these selected cytokines is depicted. Most inhibitors in clinical use inhibit more than one Jak; however, increasingly selective JAKinibs are in development. A selective Tyk2 inhibitor has yet to be reported.

Similar articles

Cited by

References

    1. Alloza I, Otaegui D, de Lapuente AL, Antiguedad A, Varade J, Nunez C, Arroyo R, Urcelay E, Fernandez O, Leyva L, et al. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci. Genes and Immunity 2011 - PubMed
    1. Batten M, Ramamoorthi N, Kljavin NM, Ma CS, Cox JH, Dengler HS, Danilenko DM, Caplazi P, Wong M, Fulcher DA, et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. The Journal of experimental medicine. 2010;207:2895–2906. - PMC - PubMed
    1. Bowes J, Orozco G, Flynn E, Ho P, Brier R, Marzo-Ortega H, Coates L, McManus R, Ryan AW, Kane D, et al. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Annals of the rheumatic diseases. 2011;70:1641–1644. - PMC - PubMed
    1. Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. Journal of Immunology. 2007;178:280–290. - PubMed
    1. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329–1337. - PMC - PubMed